Results 101 to 110 of about 45,062 (281)

Epidemiology of Japanese encephalitis: past, present, and future prospects

open access: yesTherapeutics and Clinical Risk Management, 2015
Huanyu Wang,1,2 Guodong Liang1,21State Key Laboratory for Infectious Disease Prevention and Control (SKLID), Department of Viral Encephalitis, Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention ...
Wang H, Liang G
doaj  

Vaccination with complete adjuvant-added inactivated virus vaccine of Japanese encephalitis to swine for preventing viremia (with specific reference to the effect of vaccination on viremia; epidemiological study on Japanese encephalitis. 35) [PDF]

open access: yes, 1970
As to trial toward the elimination of Japanese encephalitis virus in natural surroundings, pigs received inoculation of inactivated Japanese encephalitis vaccine supplemented with complete Freund's adjuvant twice at one-week interval.
Jitsunari, Fumihiko   +4 more
core   +1 more source

Efficacy and safety of anifrolumab across organ domains of systemic lupus erythematosus: A systematic review and meta‐analysis

open access: yesRheumatology &Autoimmunity, Volume 5, Issue 4, Page 285-296, December 2025.
A systematic review and meta‐analysis were conducted to review all clinical trial results of anifrolumab for treating systemic lupus erythematosus. Fourteen studies were included comprising 1322 patients and five studies were meta‐analyzed. It was found that anifrolumab 300 mg IV led to clinical improvement across composite lupus scores, cutaneous ...
Yomna W. Mahmoud   +11 more
wiley   +1 more source

Voltage Dependent Anion Channel Is Redistributed during Japanese Encephalitis Virus Infection of Insect Cells

open access: yesThe Scientific World Journal, 2014
Despite the availability of an effective vaccine, Japanese encephalitis remains a significant cause of morbidity and mortality in many parts of Asia.
Chanida Fongsaran   +5 more
doaj   +1 more source

Assessing global pandemic risks from emerging infectious diseases and high containment laboratory leaks: A country‐level spatial network SIR model analysis

open access: yesRisk Analysis, Volume 45, Issue 12, Page 4619-4643, December 2025.
Abstract Future pandemics could arise from several sources, notably, emerging infectious diseases (EID); and lab leaks from high containment biological laboratories (HCBL). Recent advances in infectious disease, information technology, and biotechnology provide building blocks to reduce pandemic risk if deployed intelligently.
Ross J. Tieman   +2 more
wiley   +1 more source

Culex tarsalis is a competent vector species for Cache Valley virus [PDF]

open access: yes, 2018
Background: Cache Valley virus (CVV) is a mosquito-borne orthobunyavirus endemic in North America. The virus is an important agricultural pathogen leading to abortion and embryonic lethality in ruminant species, especially sheep.
Alto, Barry W.   +10 more
core   +1 more source

Immunogenicity & safety of a single dose of live-attenuated Japanese encephalitis vaccine SA 14-14-2 in adults

open access: yesThe Indian journal of medical research, 2016
Background & objectives: Japanese encephalitis (JE) caused by mosquito-borne Flavivirus is one of the leading causes of viral encephalitis in Asia. Control strategies include vector control and human vaccination. Due to lack of immunization programmes in
S. Khan   +9 more
semanticscholar   +1 more source

How do I interpret transfusion transmissible infectious disease testing in a low‐risk donor population?

open access: yesTransfusion, Volume 65, Issue 12, Page 2236-2249, December 2025.
Abstract Background Blood donors represent a unique population. Pre‐donation screening questions, donor self‐deferral, and temporary deferral and re‐testing of repeat reactive donors result in lower prevalence of infectious disease compared to the general population.
Carmen L. Charlton   +3 more
wiley   +1 more source

The rationale for integrated childhood meningoencephalitis surveillance: a case study from Cambodia

open access: yesBulletin of the World Health Organization, 2009
PROBLEM: Recent progress in vaccine availability and affordability has raised prospects for reducing death and disability from neurological infections in children.
Sok Touch   +6 more
doaj  

Home - About - Disclaimer - Privacy